Comparison of solid tissue sequencing and liquid biopsy accuracy in identification of clinically relevant gene mutations and rearrangements in lung adenocarcinomas-Reference-Cited by-同舟云学术

Comparison of solid tissue sequencing and liquid biopsy accuracy in identification of clinically relevant gene mutations and rearrangements in lung adenocarcinomas

Published:2021-08-06 Issue:12 Volume:34 Page:2168-2174
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Lin Lawrence Hsu,Allison Douglas H. R.^ORCID,Feng Yang,Jour George,Park Kyung,Zhou Fang,Moreira Andre L.^ORCID,Shen Guomiao,Feng Xiaojun,Sabari Joshua,Velcheti Vamsidhar,Snuderl Matija,Cotzia Paolo

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

https://www.nature.com/articles/s41379-021-00880-0.pdf

Reference30 articles.

1. Brahmer, J. R. et al. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC). J Immunother Cancer 6, 1–5 (2018).

2. Arbour, K. C. & Riely, G. J. Systemic therapy for locally advanced and metastatic non–small cell lung cancer: a review. JAMA 322, 764–774 (2019).

3. Guo, Y. et al. Recent progress in rare oncogenic drivers and targeted therapy for non-small cell lung cancer. Onco Targets Ther 12, 10343–10360 (2019).

4. Canon, J. et al. The clinical KRAS (G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature 575, 217–223 (2019).

5. Nagasaka, M. et al. KRAS G12C Game of Thrones, which direct KRAS inhibitor will claim the iron throne? Cancer Treat Rev 84, 101974 (2020).

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the future of cancer diagnosis – promises and challenges of ctDNA-based liquid biopsies in non-small cell lung cancer;Translational Research;2024-10

2. Clinical Validity and Utility of Circulating Tumor DNA (ctDNA) Testing in Advanced Non-small Cell Lung Cancer (aNSCLC): A Systematic Literature Review and Meta-analysis;Molecular Diagnosis & Therapy;2024-08-02

3. Utilizing Plasma-Based Next-Generation Sequencing to Expedite the Diagnostic Process in Suspected Lung Cancer: A Case Report;International Journal of Molecular Sciences;2024-07-25

4. Plasma ctDNA enhances the tissue-based detection of oncodriver mutations in colorectal cancer;Clinical and Translational Oncology;2024-05-22

5. The cost-effectiveness of including liquid biopsy into molecular profiling strategies for newly diagnosed advanced non-squamous non-small cell lung cancer in an Asian population;Lung Cancer;2024-05